Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial

NCT05755685 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Peritoneal Metastases
Colorectal Cancer

Interventions

DRUG: Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]